EP0404283A3

11-beta-aryl-4-estrene, method for its production and its use as a medicine

Abstract

Compounds of general formula I have been described wherein X, R¹, R², R³ and R⁴ have the meaning given in the description, as well as processes for their preparation, pharmaceutical compositions containing them and their use for the treatment of diseases. Above all, the compounds possess antigestagenic and antiglucocorticoid activity.

EP0404283A3, drawing sheet 1 — Sheet 1 of 1

Term

Term ended

Projected expiry passed 1 June 2010, 16.3 years ago.

1 sheet

Sheet 1

Every citation, both ways

Citations
Document	Relation	Office	Category	Cited during
EP0192598A2	Cites	European Patent Office (EPO)	A	Search report
EP0196707A1	Cites	European Patent Office (EPO)	X	Search report
EP0277089A1	Cites	European Patent Office (EPO)	Y	Search report
EP0308345A1	Cites	European Patent Office (EPO)	Y	Search report
AU59584A	Cites	Australia	A	Search report
WO8705908A1	Cites	World Intellectual Property Organization (WIPO)	Y	Search report
WO8801868A1	Cites	World Intellectual Property Organization (WIPO)	A	Search report

39 members in 19 offices

This recordMember, by publication datePriority claim9 more offices are in the list below

Priority claims4

Priority claims
Document	Office	Kind	Date
3921059	Germany	A	1989-06-23
3921059	Germany	A	1989-06-23
3921059	Germany	–	1989-06-23
DE19893921059	–	–	–

Members39

Family members, oldest first
Document	Office	Kind
NO902800D0	Norway	D0	1990-06-22
HU903961D0	Hungary	D0	1990-11-28
CA2019404A1	Canada	A1	1990-12-23
IE902280L	Ireland	L	1990-12-23
EP0404283A2	European Patent Office (EPO)	A2	1990-12-27
NO902800L	Norway	L	1990-12-27
CN1048219A	China	A	1991-01-02
AU5778090A	Australia	A	1991-01-03
DE3921059A1	Germany	A1	1991-01-10
IE902280A1	Ireland	A1	1991-01-16
PT94462A	Portugal	A	1991-02-08
HUT54705A	Hungary	A	1991-03-28
IL94819D0	Israel	D0	1991-04-15
ZA904893B	South Africa	B	1991-04-24
JPH03128323A	Japan	A	1991-05-31
EP0404283A3This record	European Patent Office (EPO)	A3	1991-07-31
DD295639A5	German Democratic Republic (until 1990)	A5	1991-11-07
AU640664B2	Australia	B2	1993-09-02
HU209949B	Hungary	B	1994-12-28
IL94819A	Israel	A	1995-03-30
FI954748A	Finland	A	1995-10-05
NO178768B	Norway	B	1996-02-19
EP0404283B1	European Patent Office (EPO)	B1	1996-05-08
AT137762T	Austria	T	1996-05-15
NO178768C	Norway	C	1996-05-29
DE59010312D1	Germany	D1	1996-06-13
GR3020098T3	Greece	T3	1996-08-31
DK0404283T3	Denmark	T3	1996-09-09
ES2088959T3	Spain	T3	1996-10-01
CN1133296A	China	A	1996-10-16
IE74191B1	Ireland	B1	1997-07-16
US5728689A	United States of America	A	1998-03-17
US5843933A	United States of America	A	1998-12-01
JP2911553B2	Japan	B2	1999-06-23
CN1048499C	China	C	2000-01-19
CN1061052C	China	C	2001-01-24
FI110688B	Finland	B	2003-03-14
CA2019404C	Canada	C	2003-09-16
FI111844B	Finland	B	2003-09-30

58 legal events, as 7 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2005-06-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2004-09-16	Announcement of lapse in spainLapsedFD2A	FD2A	ES
2004-04-02	Notification of lapseLapsedST	ST	FR
2004-03-01	Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4	NLV4	EP
2004-02-27	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2004-02-13	Patent ceasedCeasedPL	PL	CH
2004-02-09	Ep patent lapsedLapsedEBP	EBP	DK
2004-02-03	Se: european patent has lapsedLapsedEUG	EUG	EP
2004-01-21	Gb: european patent ceased through non-payment of renewal feeCeasedGBPC	GBPC	EP
2004-01-07	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2004-01-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-12-31	Be: lapsedLapsedBERE	BERE	EP
2003-12-16	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-02	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-02	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-06-17	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-06-10	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-06-03	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-05-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-05-23	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-05-22	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-05-21	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-05-21	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-05-20	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-05-14	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-05-13	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-05-10	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-01-01	European patent in force as of 2002-01-01IF02	IF02	GB
1997-05-02	No opposition filedOpposition26N	26N	EP
1997-03-14	No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE	PLBE	EP
1997-03-14	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA	STAA	EP
1996-11-16	Definitive protectionFG2A	FG2A	ES
1996-10-01	Definitive protectionFG2A	FG2A	ES
1996-09-13	Fr: translation filedET	ET	EP
1996-09-09	Ep patent with danish claimsT3	T3	DK
1996-09-04	Gb: translation of ep patent filed (gb section 77(6)(a)/1977)GBT	GBT	EP
1996-07-31	Validation in greece3020098FG4A	FG4A	GR
1996-07-19	It: translation for a ep patent filedITF	ITF	EP
1996-07-19	It: translation for a ep patent filedITF	ITF	EP
1996-06-14	New agentNV	NV	CH
1996-06-13	Corresponds to:REF	REF	EP
1996-05-08	Designated contracting statesAK	AK	EP
1996-05-08	Corresponds to:REF	REF	EP
1996-03-22	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
1996-02-29	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH	GRAH	EP
1994-09-28	First examination report despatched17Q	17Q	EP
1991-07-31	Designated contracting statesAK	AK	EP
1991-06-12	Search report despatchedORIGINAL CODE: 0009013PUAL	PUAL	EP
1990-12-27	Request for examination filed17P	17P	EP
1990-12-27	Designated contracting statesAK	AK	EP
1990-11-10	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP

11-beta-aryl-4-estrene, method for its production and its use as a medicine

Abstract

Term

Priority claims4

Members39

Over the term

Events

Numbers

Titles3

Classification

Designated states1